Next, we evaluated the anti-proliferative activity of six rabbit antibodies (r3, r4, r5, r29, r36, r40) and the mouse antibody m66 in HER2-overexpressing BT-474 breast cancer cells (Fig 2A). Here, CD1D is linked to breast carcinoma.